Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BioAge Labs Inc shares valued at $216,000 were sold by RUBIN PAUL D on Dec 09 ’25. At $12.00 per share, RUBIN PAUL D sold 18,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, RUBIN PAUL D purchased 18,000 shares, netting a total of over 216,000 in proceeds.
Before that, RUBIN PAUL D had sold 68,897 shares from its account. In a trade valued at $701,909, the Chief Medical Officer traded BioAge Labs Inc shares for $10.19 each. Upon closing the transaction, the insider’s holdings decreased to 68,897 shares, worth approximately $0.0.
As published in a research note from Morgan Stanley on December 05, 2025, BioAge Labs Inc [BIOA] has been rated up from an Underweight to an Equal-weight and the price target has been revised to $12. Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late October. As of February 28, 2025, William Blair has initiated its “Mkt perform” rating for BIOA. Earlier on December 10, 2024, Morgan Stanley downgraded its rating. Their new recommendation was “an Underweight” for BIOA stock which previously was a “an Overweight”.
Analyzing BIOA Stock Performance
On last trading session, BioAge Labs Inc [NASDAQ: BIOA] rose 0.55% to $12.75. The stock’s lowest price that day was $12.0, but it reached a high of $13.08 in the same session. During the last five days, there has been a surge of approximately 21.43%. Over the course of the year, BioAge Labs Inc shares have jumped approximately 174.19%. Shares of the company reached a 52-week high of $13.10 on 12/11/25 and a 52-week low of $2.88 on 04/09/25.
Support And Resistance Levels for BioAge Labs Inc (BIOA)
According to the 24-hour chart, there is a support level at 12.13, which, if violated, would cause prices to drop to 11.52. In the upper region, resistance lies at 13.23. The next price resistance is at 13.72. RSI (Relative Strength Index) is 82.56 on the 14-day chart, showing overbought technical sentiment.
Is BioAge Labs Inc subject to short interest?
Stocks of BioAge Labs Inc saw a sharp rise in short interest on 2025-11-28 jumping by 39373.0 shares to 0.5 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 0.46 million shares. A jump of 7.83% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.84 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.84.
Which companies own the most shares of BioAge Labs Inc (BIOA)?
In terms of BioAge Labs Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, down nearly -5.36% from the previous closing price of $12.68. Analysts anticipate BioAge Labs Inc stock to reach 12 by 2025, with the lowest price target being 12. On December 09, 2024, Jefferies assigned a price target of “a Hold” to the stock and downgraded coverage with a $7.
